Clinical Trials
214
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (140 trials with phase data)• Click on a phase to view related trials
Multicenter Observational Study of Multimodal AI for Upper GI Mesenchymal Tumor Diagnosis
- Conditions
- Submucosal TumorGastrointestinal Stromal Tumor (GIST)LeiomyomaSchwannoma
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 130
- Registration Number
- NCT07078136
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Cofrogliptin Once Every 2 Weeks as Add-on Therapy to Metformin and Dapagliflozin Versus Daily Linagliptin in Patients With Type 2 Diabetes.
- Conditions
- T2DM
- Interventions
- Drug: SGLT2i+Metformin+CofrogliptinDrug: SGLT2i+Metformin+Linagliptin
- First Posted Date
- 2025-06-13
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 170
- Registration Number
- NCT07019012
- Locations
- 🇨🇳
Wuhan University People's Hospital, Wuhan, Hubei, China
22G-Adapt vs 22G-Franseen Needle Biopsy in EUS-Guided Tissue Acquisition of Solid Lesions
- Conditions
- Abdominal Neoplasm, Excluding Pancreas NeoplasmPancreatic NeoplasmsMediastinal Neoplasms
- First Posted Date
- 2025-06-10
- Last Posted Date
- 2025-07-01
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 576
- Registration Number
- NCT07012694
- Locations
- 🇨🇳
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
- Conditions
- Cardiopulmonary FunctionEnvironmental Exposures
- First Posted Date
- 2025-06-05
- Last Posted Date
- 2025-06-05
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 600
- Registration Number
- NCT07005193
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
- Conditions
- Sleep DisorderAging
- First Posted Date
- 2025-05-25
- Last Posted Date
- 2025-05-30
- Lead Sponsor
- Huazhong University of Science and Technology
- Target Recruit Count
- 80
- Registration Number
- NCT06990256
- Locations
- 🇨🇳
Wuchang Hospital Affiliated to Wuhan University of Science and Technology, Wuhan, Hubei, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 43
- Next
News
Neoadjuvant SCRT Plus Camrelizumab Shows Promising 3-Year Survival in Locally Advanced Rectal Cancer
A phase 2 trial demonstrated that neoadjuvant short-course radiotherapy followed by camrelizumab and CAPOX chemotherapy achieved an 80.2% three-year disease-free survival rate in locally advanced rectal cancer patients.
Gene-Edited Pig Kidney Functions in Macaque for Over Six Months in Chinese Study
Chinese scientists achieved a breakthrough by maintaining a gene-edited pig kidney's function in a macaque for 184 days, marking progress in xenotransplantation.